ESTEE LAUDER COS A DL-,01/ US5184391044 /
24.06.2024 8:00:11 | Изменение +0.50 | Объем сделки | Бид9:00:04 | Предложение9:00:04 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
105.50EUR | +0.48% | 0 Оборот: 0.00 |
105.50Величина цены спроса: 86 | 107.00Величина цены предложения: 55 | 38.17 млрдEUR | - | - |
GlobeNewswire
9:00
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Ant...
GlobeNewswire
8:39
OKX Marketplace and Astra Nova Launch Giveaway of 500 SuperNova NFT Whitelist Spots and 50 Shards
GlobeNewswire
8:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
7:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
7:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
7:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница